Exam 2 Antineoplastics Flashcards

(29 cards)

1
Q

Mechlorethamine (Mustargen): class, MOA, SE

A

Antineoplastic: alkylating agent
Part of MOPP regimen; hodgkin
Cause miscoding, breakage and cross-linking
Not cell cycle phase specific
Most effect on rapidly proliferating cells: tumor, GI, hair, bone marrow
SE: vesicant, hematologic, hyperuricemia (tx with alllopurinol), renal damage (must hydrate), N/V, Sterility, teratogenesis
BURN, BLOOD, BARF, BUN, BABY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alkylating Agent toxicity

A

Vesicant (site injection tissue damage), N/V (CTZ and local), bone marrow depression, immunosuppression, teratogenesis, infertility (incl sperm), alopecia

General: BURN, BLOOD, BARF, BALD, BABY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CYCLOPHOSPHAMIDE (cytoxan): MOA, use, SE

A
Anti neoplastic Alkylating agent
NOT a vesicant
Broad spectrum
SE: immunosuppressive, alopecia, hematologic toxicity, HEMORRHAGIC CYSTITIS, SIADH
Tx hemorrhagic cystitis with MESNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List the 3 alkylating agents

A

Mechloerthamine (Mustargen)
Cyclophosphamide (Cytoxan)
Cisplatin (Platinol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cisplatin (Platinol): MOA, use, SE

A

Antineoplastic alkylating agent
Crosslinks DNA, sensitizes cells to radiation
Use: Broad spectrum (like Cyclophosphamide)
SE: Nephrotoxic, acoustic n damage, anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the anti-metabolite agents

A
  1. Methotrexate
  2. Mercaptopurine (6MP, purinethol)
  3. 5-FU (adrucil)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Methotrexate: Class, MOA, how to decrease toxicity? Resistance, use?

A

Antineoplastic antimetabolite
Inhibits DHF reductase, no thymidylate
Blocks DNA, RNA and protein synthesis
Decrease toxicity with Leucovorin (bypass blockade)
Resistance: decrease uptake/increase amt enzyme
Wide use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is Methotrexate toxic

A
  1. Precipitates in renal tubules – need to hydrate
  2. Hepatotoxic – esp with long term use (ie immunosuppressant for RA)
  3. Myelosuppression
  4. Alopecia
  5. GI
  6. Pulmonary
  7. Teratogenic, sterility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Purine Analogues: class, use, MOA

A
Antimetabolic antineoplastics
Converted by HGPRT to nucleotide; inhibit synthesis of purine nucleotides (aka DNA, RNA)
Resistance with decreased HGPRT
Not cell cycle specific
Myelosuppressive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

6-MP: class, SE, metabolism

A

Antimetabolite antineoplastic
Purine analogue
Metab by xanthine oxidase
May cause hyperuricemia (tx with allopurinol, but will need to decrease 6MP dose)
Toxicity: Bone marrow depression, jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

5-FU class, MOA, use

A

Antimetabolite antineoplastic agent
Inhibits thymidylate synthase and thus blocks DNA synthesis (specific to G1 and S phase)
Response increased by leucovorin (FH4 needed to form thymidylate synthase complex
Broad use, topical BCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Doxorubicin (adriamycin) class, MOA, use

A

Antibiotic antineoplastic
Intercalates/STICKS into DNA, generates free radicals, effect increased by iron
Cardiotoxic esp with herceptin
Wide use
Daunorubicin makes urine turn red/orange but less cardiotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bleomycin (Blenoxane) class, MOA, efficacy, SE

A

Antibiotic Antineoplastic
Directly damages DNA
G2, M phase specific
Oral or into bladder
Highly Effective – testicular, ovarian
SE: little bone marrow depression, pulmonary fibrosis, anaphylactoid sx
*lance Armstrong wouldn’t take Bleo bc risk pulmonary fibrosis – BleNOXane – NO Oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the various mechanisms of CA chemo

A
  1. Alkylate DNA
  2. Interfere with metab (antimetabolites)
  3. Bind to microtubules
  4. Block hormones
  5. Antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Strategies for treating cancer include

A
  1. Destroy CA cells
  2. Remove CA (surgery)
  3. Prevent mets
  4. Convert tumor to normal cell
  5. Halt neoplastic cell division
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What determines the likelihood of CA tx success?

A

Better if…

a) fast growing tumor
b) high % of cells in growth fraction
c) small tumors
d) early detection (less invasive, no mets)

17
Q

How do CA cells becomes resistant to drugs

A

Changes in level/affinity of target enzymes
Decreased drug activation
Increased DNA repair
Increased salvage pathways for purines and pyrimidines
Decreased drug uptake
Increased drug efflux

18
Q

Where does tx toxicity occur

A

Rapidly growing cells

a) bone marrow (common; may lead to increased bleeding after other procedures)
b) GI tract: N/V, irritation
c) Hair follicles: alopecia
d) Renal: nephrotoxicity
e) Reproduction: infertility and teratogenesis

19
Q

Nitrogen mustard used to…

A

Treat lymphoma

20
Q

Plant Alkaloids include

A

Vinblastine, Vincristine, Paclitaxel (Taxol)

21
Q

Plant Alkaloids: MOA, use

A

Bind to tubulin, disrupt mitosis, prevent segregation of chromosomes lined up (Vinblastine and Vincristine block polymerization)
Cell cycle specific – M PHASE

Resistance due to increase P glycoprotein

22
Q

Vincristine/Vinblastine class, MOA, SE

A

Plant alkaloid antineoplastic agent
Bind to tubulin M phase
Axonal transport also uses microtubules
*Vincristine: crisps the neurons, low myelosuppression
*Vinblastine: blasts the bone marrow, less neurotoxicity

23
Q

Paclitaxel (Taxol) class MOA, use

A

Plant alkaloid antineoplastic agent
binds tubulin/microtubuline, arrests mitosis, disrupts axonal transport
Kaposis sarcoma
SE: myelosuppression, myalgias, peripheral neuropathy, hypersensitivity
Tax is toxic to tubulin

24
Q

Imatinib (Gleevec) class, MOA, use, SE

A

Tyrosine Kinase inhibitor antineoplastic
inhibits Bcr-Abl fusion protein (tx for CML)
SE: NVD, edema, myalgia, can be immunosuppressive
No immunizations, avoid if recently immunized for polio

25
Cetuximab class, moa
Epidermal growth factor inhibitor (EGF Receptor) antineoplastic
26
Erlotinib class, MOA, SE
EGF inhibitor antineoplastic Blocks ATP binding to HER1/EGFR tyrosine kinase SE: diarrhea, rash, anorexia, fatigue
27
Summarize hormones and antagonist and breast CA drugs
Prednisone: lymphoma and leukemia (MOPP) Tamoxifen: block estrogen R in breast (SE: hot flash, uterine hyperplasia) Tastuzumab (Herceptin): antibody to HER2 R (SE: cardiac toxicity esp with doxorubicin) Flutamide: anti-androgen for prostate CA
28
Bevacizumab (Avastin) MOA, use, SE
Angiogenesis VEGF Inhibitor: antineoplastic VEGF (vascular endothelial growth factor) is needed for angiogenesis, but overexpressed in tumors Decreases Blood supply and slows tumor growth Injected in eye for macular degeneration RANIBIZUMAB Risks: bleeding and thromboembolism Sunitinib (renal CA) and Sorafenib (HCC) very similar, SE similar
29
Sunitinib, Sorafenib
Similar to Bevacizumab (angiogenesis VEGF inhibitor) decreases blood supply, slows tumor growth Sunitinib: renal CA Sorafenib: HCC